Reversion of resistance in relapsing infection caused by a glycopeptide-intermediate methicillin-resistant Staphylococcus aureus isolate

@article{Huang2007ReversionOR,
  title={Reversion of resistance in relapsing infection caused by a glycopeptide-intermediate methicillin-resistant Staphylococcus aureus isolate},
  author={T.-D. Huang and Carole Almpanis and Olivier Denis and Claire Nonhoff and B{\'e}n{\'e}dicte Delaere and Youri Glupczynski},
  journal={European Journal of Clinical Microbiology & Infectious Diseases},
  year={2007},
  volume={26},
  pages={419-422}
}
Clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides, also referred to as glycopeptide-intermediate S. aureus (GISA), have been reported worldwide and been associated with glycopeptide treatment failure [1]. However, the clinical significance of strains with heterogeneousintermediate resistance… CONTINUE READING